留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿,请务必投稿前电话或邮箱咨询。联系电话:021-81871323,邮箱:yxsjzzs@163.com。敬请谅解,谢谢配合!

《药学实践与服务》编辑部

免责声明

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用,如收到邮件声称是编辑部X编辑,要求加作者微信的,请谨防财产损失!编辑部用于作者校稿时微信绑定的邮件是通过yxsjzzs@163.com发送的,标题是《药学实践与服务》XML数字出版服务微信绑定,请区分开!

脑缺血和再灌注损伤与防治机制的研究进展

吴金华 马慧萍 蒙萍 贾正平

吴金华, 马慧萍, 蒙萍, 贾正平. 脑缺血和再灌注损伤与防治机制的研究进展[J]. 药学实践与服务, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
引用本文: 吴金华, 马慧萍, 蒙萍, 贾正平. 脑缺血和再灌注损伤与防治机制的研究进展[J]. 药学实践与服务, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
WU Jinhua, MA Huiping, MENG Ping, JIA Zhengping. Mechanisms of damage and treatments of cerebral ischemia and reperfusion[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
Citation: WU Jinhua, MA Huiping, MENG Ping, JIA Zhengping. Mechanisms of damage and treatments of cerebral ischemia and reperfusion[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001

脑缺血和再灌注损伤与防治机制的研究进展

doi: 10.3969/j.issn.1006-0111.2014.06.001
基金项目: 国家科技部重大专项资助项目(2008ZXJ09014-010);甘肃省省自然科学研究基金计划项目(1107RJZA100);全军医药卫生科研基金课题(CLZ11JA06).

Mechanisms of damage and treatments of cerebral ischemia and reperfusion

  • 摘要: 总结脑缺血和再灌注损伤的发生和防治机制的研究进展,展望未来研究趋势。采用文献归纳总结的方法进行分析。脑缺血和再灌注造成的损伤与炎性反应、细胞内Ca2+超载、自由基的迅速增加、兴奋性氨基酸的大量释放等因素有关。防治脑缺血和再灌注损伤的机制主要有缩短缺血时间、阻断谷氨酸受体偶联的Na+和Ca2+内流、清除自由基、抑制凋亡、减轻炎症反应、促进神经元生长与修复等多个方面。多靶点联合治疗可能是防治脑缺血和再灌注损伤的一个方向。
  • [1] Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage[J].Neuropharmacology, 2008, 55(3): 310-318.
    [2] Yager JY, Ashwal S. Animal models of perinatal hypoxic-ischemic brain damage[J].Pedietr Neurol,2009, 40(3): 156-167.
    [3] Huang L, Chen N, Ge M, et al. Ca2+ and acidosis synergistically lead to the dysfunction of cortical GABAergic neurons during ischemia[J].Bioch Biophys Res Commun, 2010, 394(3): 709-714.
    [4] Zhang YF, Fan XJ, Li X, et al. Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels[J].Eur J Pharmacol, 2008, 586(1-3): 90-99.
    [5] Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity[J].Cell Calcium, 2010, 47(2): 122-129.
    [6] Gouriou Y, Demaurex N, Bijlenga P, et al. Mitochondrial calcium handling during ischemia-induced cell death in neurons[J].Biochimie, 2011, 93(12): 2060-2067.
    [7] Richard MJ, Connell BJ, Khan BV, et al. Cellular mechanisms by which lipoic acid confers protection during the early stages of cerebral ischemia: a possible role for calcium[J].Neurosci Res, 2011, 69(4): 299-307.
    [8] Xu J, Liu ZA, Pei DS, et al. Calcium/calmodulin-dependent kinase II facilitated GluR6 subunit serine phosphorylation through GluR6-PSD95-CaMKII signaling module assembly in cerebral ischemia injury[J].Brain Res, 2010, 1366: 197-203.
    [9] Hurtado O, Moro MA, Cardenas A, et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport[J].Neurobiol Dis 2005, 18(2): 336-345.
    [10] Arranz AM, Gottlieb M, Perez-Cerda F, et al. Increased expression of glutamate transporters in subcortical white matter after transient focal cerebral ischemia[J].Neurobiol Dis, 2010, 37(1): 156-165.
    [11] Wang L, Deng S, Lu Y, et al. Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice[J].Neuroscience, 2012, 220: 100-108.
    [12] Ye XH, Wu Y, Guo PP, et al. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion[J].Brain Res, 2010, 1323: 174-183.
    [13] Webster CM, Kelly S, Koike MA, et al. Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia[J].Neurobiol Dis, 2009, 33(2): 301-312.
    [14] del Zoppo GJ. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia[J].Neuroscience, 2009, 158(3): 972-982.
    [15] Kim BJ, Kim MJ, Park JM, et al. Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat[J].J Neurol Sci, 2009, 279(1-2): 70-75.
    [16] Corsani L, Bizzoco E, Pedata F, et al. Inducible nitric oxide synthase appears and is co-expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion[J].Exp Neurol, 2008, 211(2): 433-440.
    [17] Mohammadi MT, Shid-Moosavi SM, Dehghani GA. Contribution of nitric oxide synthase (NOS) in blood-brain barrier disruption during acute focal cerebral ischemia in normal rat[J].Pathophysiology, 2012, 19(1): 13-20.
    [18] Kubo K, Nakao S, Jomura S, et al. Edaravone, a free radical scavenger, mitigates both gray and white matter damages after global cerebral ischemia in rats[J].Brain Res, 2009, 1279: 139-146.
    [19] Nurmi A, Miettinen TK, Puolivali J, et al. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia[J].Brain Res, 2008, 1207: 174-181.
    [20] Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia[J].Glia, 2005, 50(4): 329-339.
    [21] Rosenberg GA. Matrix metalloproteinases in neuroinflammation[J].Glia,2002, 39(3): 279-291.
    [22] Xu L, Xiong X, Ouyang Y, et al. Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice[J].Neurosci Lett, 2011, 488(3): 279-282.
    [23] Qi D, Liu H, Niu J, et al. Heat shock protein 72 inhibits c-Jun N-terminal kinase 3 signaling pathway via Akt1 during cerebral ischemia[J].J Neurol Sci, 2012, 317(1-2): 123-129.
    [24] Stetler RA, Gan Y, Zhang W, et al. Heat shock proteins: cellular and molecular mechanisms in the central nervous system[J].Prog Neurobiol, 2010, 92(2): 184-211.
    [25] Barreto GE, White RE, Xu L, et al. Effects of heat shock protein 72 (Hsp72) on evolution of astrocyte activation following stroke in the mouse[J].Exp Neurol, 2012, 238(2): 284-296.
    [26] Muhammad S, Barakat W, Stoyanov S, et al. The HMGB1 receptor RAGE mediates ischemic brain damage[J].J Neurosci, 2008, 28(46): 12023-12031.
    [27] Chang WJ, Toledo-Pereyra LH. The role of HMGB1 and HSP72 in ischemia and reperfusion injury[J].J Surg Res, 2011, 166(2): 219-221.
    [28] Strbian D, Durukan A, Pitkonen M, et al. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia[J].Neuroscience, 2008, 153(1): 175-181.
    [29] Mohagheghi F, Bigdeli MR, Rasoulian B, et al. The neuroprotective effect of olive leaf extract is related to improved blood-brain barrier permeability and brain edema in rat with experimental focal cerebral ischemia[J].Phytomedicine, 2011, 18(2-3): 170-175.
    [30] Xiong ZG, Zhu XM, Chu XP, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels[J].Cell, 2004, 118(6): 687-698.
    [31] Pandey AK, Hazari PP, Patnaik R, et al. The role of ASIC1a in neuroprotection elicited by quercetin in focal cerebral ischemia[J].Brain Res, 2011, 1383: 289-299.
    [32] Lee BK, Lee DH, Park S, et al. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct[J].Brain Res, 2009, 1248: 22-30.
    [33] Kim YR, Kim HN, Jang JY, et al. Electroacupuncture confers beneficial effects through ionotropic glutamate receptors involving phosphatidylinositol-3 kinase/Akt signaling pathway in focal cerebral ischemia in rats[J].Eur J Integrat Med, 2012, 4(4): e413-e420.
    [34] Im DS, Jeon JW, Lee JS, et al. Role of the NMDA receptor and iron on free radical production and brain damage following transient middle cerebral artery occlusion[J].Brain Res, 2012, 1455: 114-123.
    [35] Benakis C, Bonny C, Hirt L. JNK inhibition and inflammation after cerebral ischemia[J].Brain Behav Immun, 2010, 24(5): 800-811.
    [36] Emanueli C. Nerve growth factor promotes angiogenesis and ateriogenesis in ischemic hindlimbs[J]. Circulation, 2002, 106(17): 2257-2262.
  • [1] 杨彬, 王作君, 陈菡, 张敬一.  基于DRGs的医院合理用药管理机制探索实践 . 药学实践与服务, 2025, 43(1): 22-25, 46. doi: 10.12206/j.issn.2097-2024.202404030
    [2] 陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼.  通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2025, 43(1): 10-16. doi: 10.12206/j.issn.2097-2024.202404008
    [3] 底雪梅, 帅文, 张其锵, 余梅香, 张海, 聂永红.  暖宫外敷方预防宫腔再粘连临床疗效回顾性分析 . 药学实践与服务, 2025, 43(7): 353-356. doi: 10.12206/j.issn.2097-2024.202411013
    [4] 彭莹, 刘欣, 聂依文, 王歆荷, 年华, 朱建勇.  三种狼毒乙醇提取物对咪喹莫特诱导的银屑病小鼠防治作用研究 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202406029
    [5] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架治疗创伤性脑损伤的研究 . 药学实践与服务, 2025, 43(2): 67-74. doi: 10.12206/j.issn.2097-2024.202406034
    [6] 张文静, 付慧, 郭小彬, 郭浩.  激活α7nAChR改善氯化钙诱导的小鼠腹主动脉瘤损伤研究 . 药学实践与服务, 2025, 43(): 1-8. doi: 10.12206/j.issn.2097-2024.202409045
    [7] 李想, 陆鸿远, 张明玉, 高欢, 姚东, 许子华.  米格列醇激活UCP1介导棕色脂肪改善冷暴露小鼠损伤的研究 . 药学实践与服务, 2025, 43(1): 1-5, 16. doi: 10.12206/j.issn.2097-2024.202404005
    [8] 张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一.  药物性肝损伤不良反应分析 . 药学实践与服务, 2025, 43(1): 26-29, 40. doi: 10.12206/j.issn.2097-2024.202404034
    [9] 晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英.  基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
    [10] 于翔, 贾培培, 李欣颖, 杨君君, 郭高峰, 陆连芳.  M2型巨噬细胞外泌体喷剂对压力性损伤的疗效及作用机制 . 药学实践与服务, 2025, 43(9): 436-442. doi: 10.12206/j.issn.2097-2024.202503066
    [11] 刘彬果, 吴葆婷, 王剑丽, 陈竹卿.  中药防治流感病毒性肺炎的作用及机制研究进展 . 药学实践与服务, 2025, 43(11): 540-547. doi: 10.12206/j.issn.2097-2024.202402033
    [12] 张俊丽, 李媛媛, 尹静, 杨鸿源, 白耀武.  咪达唑仑调节PINK1/PARKIN信号通路对缺血性脑卒中大鼠神经元损伤的影响 . 药学实践与服务, 2025, 43(6): 288-292, 312. doi: 10.12206/j.issn.2097-2024.202405024
    [13] 张紫璇, 高苑, 张利, 李佳莉, 徐希科, 祖先鹏.  中药防治急性肺损伤的活性成分及其作用机制研究进展 . 药学实践与服务, 2025, 43(9): 421-426, 474. doi: 10.12206/j.issn.2097-2024.202404079
    [14] 冯一帆, 严啸东, 张文彬, 李炳锋, 郭美丽.  菸花苷长期给药对脑缺血再灌注损伤大鼠神经功能的影响 . 药学实践与服务, 2025, 43(5): 228-234. doi: 10.12206/j.issn.2097-2024.202407038
    [15] 竺东杰, 贺新征, 邹杰, 余史丹, 李红霞.  雷公藤甲素对大鼠脑缺血再灌注损伤的影响及机制研究 . 药学实践与服务, 2025, 43(7): 339-343, 361. doi: 10.12206/j.issn.2097-2024.202311021
    [16] 钱淑雨, 李铁军.  耐碳青霉烯类肠杆菌耐药机制的研究进展 . 药学实践与服务, 2024, 42(10): 419-425. doi: 10.12206/j.issn.2097-2024.202405005
    [17] 李清, 郭宜银, 陈颖, 瞿发林, 董文燊, 戈煜.  夜宁胶囊对小鼠镇静催眠作用及其机制的研究 . 药学实践与服务, 2024, 42(8): 346-349. doi: 10.12206/j.issn.2097-2024.202211047
    [18] 徐飞, 陈瑾, 鲁育含, 李志勇.  肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
    [19] 杨念, 张博乐, 张俊霞, 张振强.  一种中药组合物对ANIT诱导的小鼠胆汁淤积肝损伤的保护作用研究 . 药学实践与服务, 2024, 42(12): 508-511, 519. doi: 10.12206/j.issn.2097-2024.202305008
    [20] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
  • 加载中
计量
  • 文章访问数:  6103
  • HTML全文浏览量:  1111
  • PDF下载量:  171
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-06-07
  • 修回日期:  2013-12-20

脑缺血和再灌注损伤与防治机制的研究进展

doi: 10.3969/j.issn.1006-0111.2014.06.001
    基金项目:  国家科技部重大专项资助项目(2008ZXJ09014-010);甘肃省省自然科学研究基金计划项目(1107RJZA100);全军医药卫生科研基金课题(CLZ11JA06).

摘要: 总结脑缺血和再灌注损伤的发生和防治机制的研究进展,展望未来研究趋势。采用文献归纳总结的方法进行分析。脑缺血和再灌注造成的损伤与炎性反应、细胞内Ca2+超载、自由基的迅速增加、兴奋性氨基酸的大量释放等因素有关。防治脑缺血和再灌注损伤的机制主要有缩短缺血时间、阻断谷氨酸受体偶联的Na+和Ca2+内流、清除自由基、抑制凋亡、减轻炎症反应、促进神经元生长与修复等多个方面。多靶点联合治疗可能是防治脑缺血和再灌注损伤的一个方向。

English Abstract

吴金华, 马慧萍, 蒙萍, 贾正平. 脑缺血和再灌注损伤与防治机制的研究进展[J]. 药学实践与服务, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
引用本文: 吴金华, 马慧萍, 蒙萍, 贾正平. 脑缺血和再灌注损伤与防治机制的研究进展[J]. 药学实践与服务, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
WU Jinhua, MA Huiping, MENG Ping, JIA Zhengping. Mechanisms of damage and treatments of cerebral ischemia and reperfusion[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
Citation: WU Jinhua, MA Huiping, MENG Ping, JIA Zhengping. Mechanisms of damage and treatments of cerebral ischemia and reperfusion[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 401-404,447. doi: 10.3969/j.issn.1006-0111.2014.06.001
参考文献 (36)

目录

    /

    返回文章
    返回